about
Transition Metal Intercalators as Anticancer Agents-Recent AdvancesInhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis.The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening.Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.Development of second-generation indole-based dynamin GTPase inhibitors.Control of hepatitis C: a medicinal chemistry perspective.The discovery of allyltyrosine based tripeptides as selective inhibitors of the HIV-1 integrase strand-transfer reaction.Identification and validation of small molecule modulators of the NusB-NusE interaction.Small molecule Hedgehog pathway antagonists.Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective.Control of HIV through the inhibition of HIV-1 integrase: a medicinal chemistry perspective.The expanding utility of continuous flow hydrogenation.Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.Quinolone-1-(2H)-ones as hedgehog signalling pathway inhibitors.Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells.Norcantharidin analogues with nematocidal activity in Haemonchus contortus.Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge Cymbastela hooperi.The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells.Calcineurin activity is required for the completion of cytokinesis.Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.Defining the mechanisms by which the reactive oxygen species by-product, 4-hydroxynonenal, affects human sperm cell function.The antiplasmodial activity of norcantharidin analogs.Efficient phosphine-mediated formal C(sp3)-C(sp3) coupling reactions of alkyl halides in batch and flow.Discovery of acrylonitrile-based small molecules active against Haemonchus contortusHedgehog signalling pathway inhibitors as cancer suppressing agentsSmall-Molecule Inhibitors of the NusB-NusE Protein-Protein Interaction with Antibiotic ActivityAn efficient continuous flow approach to furnish furan-based biarylsInvestigation of the one-pot synthesis of quinolin-2-(1H)-ones and the discovery of a variation of the three-component Ugi reactionThe renascence of continuous-flow peptide synthesis - an abridged account of solid and solution-based approachesStructure-Activity Relationship Studies of Small Molecule Modulators of the Staphylococcal Accessory Gene RegulatorImmobilized Carbodiimide Assisted Flow Combinatorial Protocol to Facilitate Amide Coupling and LactamizationSynthetic strategies to access staphylococcus auto-inducing peptides as quorum sensing modulatorsSynthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues
P50
Q28077365-523ABB7E-22C8-41B1-B5F8-B1842FD52135Q33449747-528F9AC8-77B9-4F19-8F30-EE8B3147573CQ33567033-1434AA4E-1441-4405-B50D-476A29E19634Q33615048-5B38D569-40B7-4B00-AED2-DDF2924FE0D1Q33998118-E401A77A-2763-4DC6-80E0-22CDD9930B28Q34483476-DDD3FCDA-6E08-482A-9320-0E605C2A7E0BQ36000824-4B030A58-0565-4021-B682-563C9793E95DQ36029560-7A6B7A4D-73B3-46EA-A019-B10239779C7CQ36222699-FE24E556-278E-4D05-AEDB-E0A1D2235BFDQ36314340-0A8F07D7-3334-4633-8AB0-7B9CEB38A626Q36648854-49D389AD-920E-4756-B496-7C4953389A4CQ36755838-5B47855F-BD68-4F9E-96E9-19561710825CQ38527433-884F3E5E-E170-40A2-97D9-F6387B5D578EQ38727476-04EFC8BF-E964-43E2-BE41-CC652540309EQ38766060-CB86CA3C-EB6C-4521-83C6-86EE03C7EAD0Q39507927-68434A47-42AB-4D31-AB29-4A412ADF805AQ39549796-AEED08AE-417B-45AC-9B1E-023331862F55Q39603668-9DC78CFA-A645-43AE-8FF0-31C61FAB4EECQ39689337-982E67B9-C766-49BC-AFFA-256E6419A1B4Q39701097-0620CCF8-3753-4B04-ACB6-25639C654CFCQ39913573-7DB451CC-C723-4250-8404-C5D39D0D6F39Q41447823-64E1DE8B-E1C9-4518-8C44-3479C6374823Q41934832-7A4E2294-2967-403D-99B5-FCA6275A9BA2Q53708379-907BBD1B-8D89-460B-8AB5-D82110E6CBBDQ56985692-BFC75C31-AE12-4616-A88F-B037EAC81212Q57905193-F33D210E-2A33-4F76-B277-66208C9029DFQ58200362-502413C7-CE3F-463F-8408-AE39B6716393Q58200371-16C7A8DD-D8A7-4C88-A08F-FAD1201474AEQ58200418-55748749-5820-4E74-86FA-0DC292341E8EQ89678619-DD84A72C-43D7-4826-81C8-9997AC04108FQ90971461-57FE7831-1846-4E20-8478-A022823727C2Q91862984-A812D7ED-F87B-452D-8BA6-E78EA64DADCBQ92030554-0F175833-4743-4DC7-BA75-4CE82C657EA2Q92778242-840361B2-7854-427B-AB89-9FDE212718BE
P50
description
australischer Chemiker
@de
chemist from Australia
@en
հետազոտող
@hy
name
Christopher Gordon
@ast
Christopher Gordon
@de
Christopher Gordon
@en
Christopher Gordon
@es
Christopher Gordon
@nl
Christopher Gordon
@sl
type
label
Christopher Gordon
@ast
Christopher Gordon
@de
Christopher Gordon
@en
Christopher Gordon
@es
Christopher Gordon
@nl
Christopher Gordon
@sl
prefLabel
Christopher Gordon
@ast
Christopher Gordon
@de
Christopher Gordon
@en
Christopher Gordon
@es
Christopher Gordon
@nl
Christopher Gordon
@sl
P1053
D-1135-2012
P106
P1153
8782998400
P21
P31
P3829
P496
0000-0001-7583-5609